Quality agreements, tech transfer, and risk management in cell and gene therapy
Luciana Mansolelli, Audrey Chang, Ph.D.
Enzymatic versus plasmid DNA for rAAV production: early development insights that lead to manufacturing success
Leticia Agundez, PhD, Elisa Da Silva Ferrada, PhD
Accelerating digitization in cell & gene therapy manufacturing: real-world insights & practical strategies
R Street-Howard, T Ala, C Baldwin et al
10 December 2025
Register
Advancing RNA production: real-time quality, predictive control, and the future of intelligent biomanufacturing
Aaron Cowley, Edita Botonjic-Sehic, Daniel Spurgin
09 December 2025
Register
Automating and scaling adherent cell manufacturing for clinical and commercial success
Nathan Frank, Mandana Haack-Sørensen
Development and scale-up of a transient transfection rAAV process to a next-generation, single-use bioreactor system
Kelly Cybulski, Kyle Burrell
04 December 2025
Innovator Insight
Multiple CQAs from a single dataset: advancing lentiviral vector-based cell & gene therapy
Tilak Gupta, Rengarajan Pelapur, Jana Škařupová
Process optimization and digital integration strategies to scale cell and gene therapy
H Negre, N Glaserman, M Djemai et al
Key considerations for selecting raw materials in gene therapy manufacturing: expertise, scalability and compliance
Amelie Bauer, Ulrike Strauss, Nicholas DePrimo
De-risking clinical trials and enabling innovation: key strategies for empowering emerging biotechs
A Moore, L Timmerman, J Gordon et al
02 December 2025
Innovator Insight
Genetic integrity testing of genome-edited pluripotent stem cell lines used for cell therapy applications
P Hublitz, V Patel, H Philippon et al
26 November 2025
Innovator Insight
Unlock advanced strategies in cell therapy analytics
S Krause, K Shum, A Chandran et al
Scaling AAV5 production from bench to industrial scale: strategies for efficient, de-risked manufacturing
Anne MacIntyre, Sara Krekels